NewCardio to Present at OneMedForum 2009: Disrupters and Drivers on January 13 in San...(es as to the occurrence or nonoccurrence...),Health

Date:1/7/2009

es as to the occurrence or nonoccurrence of future events. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including the potential risks and uncertainties set forth in Item 1A of our Annual Report on Form 10-K/A (No. 2) for the year ended December 31, 2007 and relate to our business plan, our business strategy, development of our proprietary technology platform and our products, timing of such development, timing and results of clinical trials, level and timing of FDA regulatory clearance or review, market acceptance of our products, protection of our intellectual property, implementation of our strategic, operating and people initiatives, benefits to be derived from personnel and directors, ability to commercialize our products, our assumptions regarding cash flow from operations and cash on-hand, the amount and timing of operating costs and capital expenditures relating to the expansion of our business, operations and infrastructure, implementation of marketing programs, our key agreements and strategic alliances, our ability to obtain additional capital as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. We assume no obligation to, and do not currently intend to, update these forward-looking statements.

To join our email distribution please click this link: http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0

    Investor Contact:
    Hayden IR
    Jeff Stanlis, VP of Communications
    (602) 476-1821
    '/>"/>
SOURCE  NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 
Related medicine news :

1. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
2. NewCardio Announces New Client Services Team
3. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
4. Endocare to Present at 2nd Annual OneMedForum
5. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
6. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at JPMorgan Healthcare Conference
8. AMERIGROUP Corporation to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14
9. Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco
10. IPC The Hospitalist Company, Inc. to Present at 27th Annual J.P. Morgan Healthcare Conference
11. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference